atovaquone has been researched along with AIDS-Related Opportunistic Infections in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 44 (72.13) | 18.2507 |
| 2000's | 12 (19.67) | 29.6817 |
| 2010's | 4 (6.56) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Hikosaka, K; Miyata, N; Norose, K; Tachikawa, N; Yoshimura, Y | 1 |
| Fukutake, K; Sekine, Y; Shinozawa, K; Yamamoto, Y; Yotsumoto, M | 1 |
| Alfaro, RM; Calderón, MM; Kovacs, JA; Kumar, P; McManus, M; Pau, AK; Penzak, SR | 1 |
| Ball, SC; O'Neal, CB | 1 |
| Bellamy, RJ | 1 |
| Dean, SR; Hidalgo, K; Lyles, A | 1 |
| Borde, JP; de With, K; Offensperger, WB | 1 |
| James, CW; McNelis, KC; Szabo, S | 1 |
| Ioannidis, J; Wilkinson, D | 2 |
| Dankner, WM; Flores, MA; Huang, S; Hughes, WT; Kline, MW; Paul, ME; Wei, LJ; Yogev, R | 1 |
| Cantrill, HL; Holland, EJ; Shah, GK | 1 |
| Bagneres, D; Cretel, E; Durand, JM; Guillemot, E; Kaplanski, G; Soubeyrand, J | 1 |
| Winstanley, P | 1 |
| Goa, KL; Spencer, CM | 1 |
| Althaus, C; Armbrecht, C; Jablonowski, H; Schimkat, M; Sundmacher, R | 1 |
| Nüesch, R | 1 |
| Hughes, WT; LaFon, SW; Masur, H; Scott, JD | 1 |
| Andrews, E; Brown, N; LaFon, S; Rogers, M; White, A | 1 |
| Bouboulis, DA; Frieri, M; Madden, J; Rubinstein, A; Shliozberg, J | 1 |
| Lederman, MM; van der Horst, C | 1 |
| Stoeckle, M; Tennenberg, A | 1 |
| Hughes, WT | 2 |
| Caldwell, PT; Deresinski, SC; Dohn, MN; Follansbee, SE; Gathe, JC; Haghighat, DP; Lancaster, DJ; Meyer, RD; Sampson, JH; Scott, JD; Spotkov, J; Torres, RA; Weinberg, WG | 1 |
| Lizasoain, M; Lumbreras, C; Pastor, C | 1 |
| Daar, ES; Epstein, LJ; Meyer, RD; Mohsenifar, Z; Yeh, V | 1 |
| Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L | 1 |
| Fisher, MJ; Gazzard, BG; Hawkins, DA; Nelson, MR | 1 |
| Chouette, I; Lafeuillade, A; Navarreté, MS; Pellegrino, P; Poggi, C; Profizi, N; Quilichini, R | 1 |
| Flaherty, JF; Haile, LG | 1 |
| Finley, R | 1 |
| Meyer, C | 1 |
| Bozzette, SA; Chan, C; Clumeck, N; Frame, P; Hughes, W; Kramer, F; Lancaster, D; Leoung, G; Masur, H; Safrin, S | 1 |
| Bogner, JR; Goebel, FD | 1 |
| Balducci, M; Burzacchini, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Korraa, H; Saadeh, C | 1 |
| Anwar-Bruni, DM; Bryan, RT; Hogan, SE; Lennox, JL; Schwartz, DA; Wilcox, CM | 1 |
| McKendrick, MW; Nash, C; Vilar, FJ | 1 |
| Kovacs, J; Leoung, G; Rogers, M; Scott, J; Stansell, J; Torres, RA; Weinberg, W | 1 |
| Deresinski, SC | 1 |
| Beauchamp, B; Dorenbaum, A; Hughes, W; McNamara, J; Moye, J; Purdue, L; Rogers, M; Sadler, B; van Dyke, R; Xu, J; Yogev, R | 1 |
| Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC | 1 |
| Bryan, E; McFarland, J; Sackoff, J; Su, S | 1 |
| Balfour, HH; Cheung, TW; El-Sadr, WM; Eng, R; Hafner, R; Hooton, TM; Kerkering, TM; Luskin-Hawk, R; Murphy, RL; Schutz, M; van der Horst, C; Yurik, TM | 1 |
| Horowitz, HW; Wormser, GP | 1 |
| Caldwell, P; Chan, C; Dohn, M; Lefebvre, EA; Marina, R; McIvor, RA; Montaner, J; Morey, G; Scott, J | 1 |
| Cheung, TW | 1 |
| Bechtel, C; Davey, RT; Falloon, J; Kovacs, JA; LaFon, SW; Lane, HC; Masur, H; Piscitelli, SC; Polis, MA; Sadler, B; Sargent, S; Walker, RE | 1 |
| Braun, J; Caldwell, PT; Chan, CK; Dohn, MN; McCarthy, W; Montaner, J; Rosenberg, DM; Slavinsky, J | 1 |
| Chaloner, K; Rhame, FS | 1 |
| Walker, MJ | 1 |
| Cadman, J; Torres, G | 1 |
| Groll, AH; Müller, FM; Ritter, J | 1 |
| Gill, VJ; Kovacs, JA; Masur, H; Meshnick, S | 1 |
| Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL | 1 |
| Cohen, CJ; Craven, DE; Freedberg, KA; Goldie, SJ; Kaplan, JE; Kimmel, AD; Losina, E; Paltiel, AD; Seage, GR; Weinstein, MC; Zhang, H | 1 |
| Masur, H | 1 |
13 review(s) available for atovaquone and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
HIV: treating Pneumocystis pneumonia (PCP).
Topics: Administration, Oral; Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Atovaquone; HIV Infections; Humans; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
[Diagnosis and treatment of pneumocystis jirovecii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Bronchoalveolar Lavage Fluid; Caspofungin; Diagnosis, Differential; Echinocandins; Humans; Lipopeptides; Lung; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 2011 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis | 1995 |
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
[Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimetrexate | 1994 |
Atovaquone: a review.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Trials as Topic; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis, Cerebral | 1993 |
[Therapy and prevention of pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Dapsone; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Humans; Leucovorin; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1996 |
Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Humans; Infusions, Intravenous; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1997 |
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Naphthoquinones; Neoplasms; Odds Ratio; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Clinical Trials as Topic; Drug Tolerance; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
15 trial(s) available for atovaquone and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
Topics: Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Infective Agents; Atazanavir Sulfate; Atovaquone; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Encephalitis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Ritonavir; Toxoplasmosis, Cerebral; Young Adult | 2016 |
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Atovaquone; Azithromycin; Bacterial Infections; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Child; Child, Preschool; Drugs, Investigational; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis | 1995 |
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Cohort Studies; Humans; Male; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Rats; Tablets; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Survival Analysis; Treatment Outcome | 1994 |
Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Outcome | 1994 |
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthoquinones; Odds Ratio; Pneumonia, Pneumocystis; Regression Analysis; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naphthoquinones; Salvage Therapy; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1997 |
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Child; Child, Preschool; Humans; Infant; Naphthoquinones; Pneumonia, Pneumocystis | 1998 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service | 1998 |
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Grou
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Female; Follow-Up Studies; HIV Infections; Humans; Male; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim | 1999 |
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Fasting; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Drug Therapy, Combination; Encephalitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Time Factors; Toxoplasma; Treatment Outcome | 2002 |
34 other study(ies) available for atovaquone and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
Topics: Adult; AIDS-Related Opportunistic Infections; Atovaquone; Brain; Clindamycin; Coccidiostats; Desensitization, Immunologic; Humans; Male; Toxoplasmosis, Cerebral; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
[Status of use and side effects of atovaquone for the treatment and prevention of pneumocystis pneumonia in HIV infected patients in Japan--from 1997 to 2012--The Clinical Study Group for AIDS Drugs, supported by Health and Labor Science Grants from the M
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Humans; Male; Middle Aged; Pneumonia, Pneumocystis | 2013 |
Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atovaquone; Female; HIV; HIV Infections; Humans; Immunohistochemistry; Pentamidine; Pneumocystis carinii; Pneumocystis Infections; Polymerase Chain Reaction; Spleen; Splenic Diseases; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
A potential interaction between warfarin and atovaquone.
Topics: AIDS-Related Opportunistic Infections; Anticoagulants; Antifungal Agents; Atovaquone; Drug Interactions; Drug Monitoring; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Pulmonary Embolism; Risk Factors; Venous Thrombosis; Vitamin K; Warfarin | 2011 |
Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Atovaquone; Clinical Protocols; Dapsone; Drug Therapy, Combination; HIV Infections; Hospital Administration; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Retreatment; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Vortex keratopathy associated with atovaquone.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Cornea; Corneal Diseases; Epithelium; Humans; Male; Middle Aged; Naphthoquinones; Pneumonia, Pneumocystis | 1995 |
Failure of atovaquone in the treatment of cerebral toxoplasmosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Female; Humans; Naphthoquinones; Toxoplasmosis, Cerebral; Treatment Failure | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Atovaquone; Clindamycin; Coccidiostats; Humans; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Cerebral | 1995 |
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient].
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Naphthoquinones; Toxoplasmosis, Ocular | 1995 |
[A case from practice (320). 1. Drug-induced fever. 2. HIV infection C3. multiple Kaposi sarcomas of the skin. Status after cerebral toxoplasmosis, PCP, herpes zoster. status after syphilis and gonorrhea].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Fever; HIV Infections; Humans; Male; Naphthoquinones | 1995 |
Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Child; Desensitization, Immunologic; Female; HIV Infections; Humans; Naphthoquinones; Pyrimethamine; Toxoplasmosis, Cerebral | 1995 |
Atovaquone for Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Failure | 1995 |
Atovaquone for Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Treatment Failure | 1995 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug Therapy, Combination; Folic Acid; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral | 1994 |
Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Immunocompromised Host; Naphthoquinones; Pneumonia, Pneumocystis | 1994 |
[Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Drug Resistance, Microbial; Humans; Naphthoquinones; Toxoplasmosis, Cerebral | 1993 |
Deceptive X-ray films in an advertisement.
Topics: Advertising; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Radiography; X-Ray Film | 1993 |
A banner year for AIDS therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Infections; Humans; Itraconazole; Ketoconazole; Naphthoquinones; Rifabutin; Rifamycins; United States; United States Food and Drug Administration; Zalcitabine | 1993 |
Mepron for AIDS-related pneumonia.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Drug Approval; Humans; Naphthoquinones; Pneumonia, Pneumocystis; United States; United States Food and Drug Administration | 1993 |
In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Humans; Microbial Sensitivity Tests; Naphthalenes; Naphthoquinones; Pneumocystis; Pneumonia, Pneumocystis; Terbinafine; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Cohort Studies; HIV-1; Humans; Intestines; Male; Microsporida; Naphthoquinones; Protozoan Infections; Retrospective Studies | 1996 |
Atovaquone as prophylaxis for Pneumocystis carinii.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Female; Humans; Naphthoquinones; Pneumonia, Pneumocystis | 1996 |
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Morbidity; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Prospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1998 |
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Drug Costs; HIV Infections; Humans; Naphthoquinones; Pneumonia, Pneumocystis | 1999 |
Overdose of atovaquone in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Drug Overdose; Humans; Naphthoquinones; Pneumonia, Pneumocystis | 1999 |
Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; Naphthoquinones; Pharmaceutical Solutions; Pneumonia, Pneumocystis; Retrospective Studies; Tablets; Treatment Outcome | 2001 |
Quantifying and documenting prior beliefs in clinical trials.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Attitude of Health Personnel; Bayes Theorem; Clinical Trials as Topic; Dapsone; Ethics, Medical; HIV Infections; Humans; Naphthoquinones; Physicians; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; Sample Size; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasis; Clinical Trials as Topic; Cryptosporidiosis; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunotherapy; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Paromomycin; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis; Tuberculosis | 1995 |
Optimizing PCP therapy.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Encephalitis; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Anti-Infective Agents; Atovaquone; Dihydropteroate Synthase; Drug Resistance, Fungal; Fungal Proteins; Humans; Lymphoma, AIDS-Related; Male; Membrane Glycoproteins; Middle Aged; Mutation; Naphthoquinones; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; CD4 Lymphocyte Count; Cost-Benefit Analysis; Dapsone; Drug Costs; Humans; Life Expectancy; Models, Theoretical; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Quality-Adjusted Life Years | 2002 |
New drug offers alternative treatment for PCP.
Topics: AIDS-Related Opportunistic Infections; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
New oral agent for PCP is effective, well tolerated.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis | 1992 |